...
首页> 外文期刊>Molecular Immunology >Major mountain cedar allergen, Jun a 1, contains conformational as well as linear IgE epitopes.
【24h】

Major mountain cedar allergen, Jun a 1, contains conformational as well as linear IgE epitopes.

机译:主要的雪松变应原Jun 6,包含构象和线性IgE表位。

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously identified four linear IgE epitopes on Jun a 1, the dominant allergen in mountain cedar pollen, and mapped these to the surfaces of a molecular model and to the crystal structure of this glycoprotein. The aim of the present study was to determine if Jun a 1 also displays conformational IgE epitopes. Jun a 1 was denatured by heating at 75 degrees C for 1h, exposure to 6M guanidine or by reductive alkylation in the presence and absence of guanidine. The effects of these manipulations on the binding to IgE from patients with mountain cedar hypersensitivity was evaluated by an ImmunoCAP inhibition assay, using Jun a 1-specific caps. Treatment-associated changes in the 3D-structure were assessed by dynamic light scattering and CD spectroscopy. IgE binding to native Jun a 1 was inhibited 92+/-9% by soluble native protein and 92+/-9% by reduced and alkylated Jun a 1. However, the capacity of Jun a 1 to inhibit the binding of IgE antibodies was significantly diminished upon denaturation by heat, guanidine alone, or reduction and alkylation in guanidine, compared to native Jun a 1. Reductive alkylation treatment under denaturing conditions also increased the Stoke's radius, suggesting that the protein was partially unfolded. Analysis of the circular dichroism (CD) spectra suggested that heating and treatment with guanidine caused a loss of alpha-helical structure. Guanidine also caused an increase in random coil structure. Thus, at least a portion of the anti-Jun a 1 IgE antibodies produced by allergic humans recognize conformational epitopes and it is likely that some of these epitopes reside in alpha-helical structures of Jun a 1.
机译:我们之前已经确定了Jun a 1上的四个线性IgE表位(雪松花粉中的主要变应原),并将它们映射到分子模型的表面和该糖蛋白的晶体结构。本研究的目的是确定Jun a 1是否也显示构象IgE表位。通过在75摄氏度下加热1h,暴露于6M胍或在存在和不存在胍的条件下进行还原烷基化使Jun a 1变性。通过ImmunoCAP抑制试验,使用Jun 1特异帽,评估了这些操作对山mountain超敏反应患者与IgE结合的影响。通过动态光散射和CD光谱评估3D结构中与治疗相关的变化。 IgE与天然Jun a 1的结合被可溶性天然蛋白抑制了92 +/- 9%,被还原和烷基化的Jun a 1抑制了92 +/- 9%。然而,Jun a 1抑制IgE抗体结合的能力为与天然的Jun a 1相比,通过加热,单独的胍或在胍中的还原和烷基化进行变性后,其显着降低。在变性条件下进行还原性烷基化处理也增加了斯托克半径,这表明该蛋白质已部分展开。圆二色性(CD)光谱的分析表明,加热和胍处理导致α-螺旋结构的损失。胍也引起无规卷曲结构的增加。因此,变态反应人类产生的至少部分抗Jun 1 IgE抗体识别构象表位,并且这些表位中的某些可能位于Jun 1的α螺旋结构中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号